OR (95% CI) | P value | OR (95% CI) | P value | |
≥50% decrease | ≥75% decrease | |||
CLASI-A | ||||
Intercept | 0.067 (0.013 to 0.339) | 0.001 | 0.021 (0.003 to 0.180) | <0.001 |
Current smoker | 0.816 (0.329 to 2.021) | 0.66 | 0.376 (0.067 to 2.116) | 0.27 |
SCLE | 1.724 (0.537 to 5.536) | 0.36 | 5.666 (1.563 to 20.541) | 0.008 |
Age CLE developed* | 1.612 (1.127 to 2.304) | 0.009 | 1.616 (1.015 to 2.574) | 0.04 |
≥20% decrease | ≥40% decrease | |||
CLASI-D | ||||
Intercept | 1.124 (0.437 to 2.888) | 0.81 | 0.923 (0.298 to 2.857) | 0.89 |
Initial CLASI-A† | 0.625 (0.427 to 0.915) | 0.02 | 0.514 (0.312 to 0.846) | 0.009 |
African-American | 0.399 (0.172 to 0.929) | 0.03 | 0.253 (0.078 to 0.823) | 0.02 |
Positive ANA | 0.631 (0.255 to 1.559) | 0.32 | 0.389 (0.126 to 1.199) | 0.10 |
*Per 10 years.
†Per 5 CLASI points.
CLASI-A, Cutaneous Lupus Activity and Severity Index–Activity; CLASI-D, Cutaneous Lupus Activity and Severity Index–Damage; CLE, cutaneous lupus erythematosus; SCLE, subacute cutaneous lupus erythematosus.